In this article
Eli Lilly
on Tuesday said it will spend $6 billion to build a manufacturing plant in Huntsville, Alabama, to help boost production of its closely watched experimental obesity pill and other drugs.
It is the third facility in a string of new planned U.S. investments by the drugmaker. Eli Lilly announced in February that it would spend at least $27 billion to build four new domestic manufacturing plants, adding to $23 billion in previous investments since 2020.
The company said it expects construction of the Alabama plant to start in 2026 and for it to be completed in 2032.
